This does not affect product safety or performance, but may impact your experience
A Personalized Protocol Your path to radiance is unique, so we design a custom protocol with the precise dosage and frequency to match your individual health goals
Even safety data on TB-500 (synthetic TB4) is relatively scarce, with only a few studies reporting the potential side effects of its systemic application: In a 2010 study in 10 participants, TB4 caused occasional mild to moderate symptoms like headache and dizziness but no serious reactions or toxicities, even at doses up to 1260mg, administered daily for up to two weeks
These compounds play roles in normal metabolic processes and liver function as documented in the nutritional and clinical literature
HUBERMAN: Both are FDA approved for certain purposes
Dysesthesia The TRIUMPH-4 trial data revealed a notable safety signal: dysesthesia (abnormal sensations like tingling, burning, or numbness) was reported in 8.8% of participants on the 9 mg dose and 20.9% on the 12 mg dose of retatrutide